Search results for "From ACP Journal Club"


 
Results 1 - 10 of about 113 for "From ACP Journal Club".

From ACP Journal Club

receptor agonists (GLP-1 RAs) in diabetes patients who have or are at high risk for cardiovascular (CV) disease, an ACP Journal Club commentary said. ... Kristin Newby, MD, MHS, was published in the ACP Journal Club section of Annals of Internal Medicine
March 2022

From ACP Journal Club

overweight, have high risk for atherosclerotic cardiovascular (CV) disease, and have no gastrointestinal symptoms, an ACP Journal Club summary said. ... The following commentary by Madhusree Singh, MD, was published in the ACP Journal Club section of
March 2022

From ACP Journal Club

patients with diabetes and elevated cardiovascular risk, but cost remains a barrier, an ACP Journal Club commentary said. ... The following commentary by Gunjan Y. Gandhi, MD, MSc, was published in the ACP Journal Club section of the Nov.
December 2020

From ACP Journal Club

are needed, an ACP Journal Club commentary said. ... in the ACP Journal Club section of the March 17 Annals of Internal Medicine.
April 2020

From ACP Journal Club

either device, although real-time monitoring may be beneficial for those with more hypoglycemia issues, an ACP Journal Club commentary said. ... The following commentary by Darin E. Olson, MD, PhD, was published in the ACP Journal Club section of Annals
October 2021

From ACP Journal Club

https://diabetes.acponline.org/archives/2019/06/14/6.htm. An ACP Journal Club commentary recommends advising patients with type 2 diabetes who don't smoke and who take metformin to ... The review was published in the January Diabetes Care. The following
June 2019

From ACP Journal Club

The following commentary by Reema Shah, MD, was published in the ACP Journal Club section of the July 17 Annals of Internal Medicine. ... All articles from the August 10, 2018, ACP Diabetes Monthly Newsletter.
August 2018

From ACP Journal Club

https://diabetes.acponline.org/archives/2018/05/11/7.htm. Exenatide is still an effective alternative for patients who cannot tolerate semaglutide due to gastrointestinal adverse events, noted the ACP Journal ... in the ACP Journal Club section of the
May 2018

From ACP Journal Club

randomized trial should reassure patients of the favorable long-term benefits and safety of this intervention, an ACP Journal Club commentary said. ... Lipscombe, MD, MSc, was published in the ACP Journal Club section of Annals of Internal Medicine on
June 2021

From ACP Journal Club

kidney disease (CKD) based on consistent trial data showing their effectiveness, noted an ACP Journal Club commentary. ... The following commentary by Thomas Karagiannis, MD, MSc, PhD, Apostolos Tsapas, MD, PhD, MSc(Oxon), and Eleni Bekiari, MD, MSc, PhD,
March 2021

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next